Ingevity (NGVT)
(Delayed Data from NYSE)
$40.25 USD
+0.88 (2.24%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $40.23 -0.02 (-0.05%) 7:44 PM ET
5-Strong Sell of 5 5
C Value D Growth C Momentum D VGM
Balance Sheet
Fiscal Year End for Ingevity Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 96 | 77 | 275 | 258 | 57 |
Receivables | 182 | 225 | 162 | 148 | 150 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 309 | 335 | 241 | 189 | 213 |
Other Current Assets | 72 | 43 | 47 | 34 | 44 |
Total Current Assets | 659 | 679 | 725 | 629 | 463 |
Net Property & Equipment | 762 | 799 | 720 | 704 | 665 |
Investments & Advances | 178 | 188 | 76 | 74 | 73 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 12 | 6 | 7 | 8 | 5 |
Intangibles | 864 | 923 | 780 | 819 | 833 |
Deposits & Other Assets | 82 | 86 | 110 | 53 | 50 |
Total Assets | 2,623 | 2,737 | 2,469 | 2,335 | 2,142 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 84 | 1 | 20 | 26 | 23 |
Accounts Payable | 158 | 175 | 126 | 104 | 99 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 92 | 108 | 100 | 72 | 62 |
Income Taxes Payable | 9 | 4 | 6 | 5 | 15 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 363 | 304 | 269 | 223 | 216 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 71 | 107 | 115 | 117 | 100 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,383 | 1,473 | 1,250 | 1,267 | 1,228 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 127 | 115 | 126 | 50 | 30 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,992 | 2,038 | 1,795 | 1,692 | 1,611 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 165 | 153 | 136 | 121 | 113 |
Retained Earnings | 1,002 | 1,008 | 796 | 678 | 497 |
Other Equity | -27 | -47 | 13 | 5 | -5 |
Treasury Stock | 510 | 416 | 272 | 162 | 75 |
Total Shareholder's Equity | 631 | 698 | 674 | 642 | 531 |
Total Liabilities & Shareholder's Equity | 2,623 | 2,737 | 2,469 | 2,335 | 2,142 |
Total Common Equity | 631 | 698 | 674 | 642 | 531 |
Shares Outstanding | 36.20 | 37.30 | 39.20 | 41.20 | 41.80 |
Book Value Per Share | 17.44 | 18.72 | 17.19 | 15.58 | 12.70 |
Fiscal Year End for Ingevity Corporation falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 107 | 89 | 96 | 85 | 68 |
Receivables | 213 | 191 | 182 | 217 | 260 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 302 | 326 | 309 | 387 | 387 |
Other Current Assets | 63 | 64 | 72 | 47 | 50 |
Total Current Assets | 686 | 669 | 659 | 735 | 764 |
Net Property & Equipment | 722 | 727 | 762 | 800 | 801 |
Investments & Advances | 174 | 174 | 178 | 180 | 179 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 81 | 24 | 12 | 6 | 7 |
Intangibles | 473 | 829 | 864 | 896 | 921 |
Deposits & Other Assets | 80 | 81 | 82 | 82 | 90 |
Total Assets | 2,276 | 2,567 | 2,623 | 2,767 | 2,828 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 103 | 85 | 84 | 3 | 1 |
Accounts Payable | 142 | 153 | 158 | 197 | 204 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 91 | 87 | 92 | 81 | 84 |
Income Taxes Payable | 3 | 8 | 9 | 5 | 5 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 358 | 352 | 363 | 305 | 311 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 62 | 64 | 71 | 105 | 110 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,401 | 1,409 | 1,383 | 1,470 | 1,526 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 129 | 127 | 118 | 119 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,991 | 1,999 | 1,992 | 2,048 | 2,114 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 172 | 169 | 165 | 163 | 164 |
Retained Earnings | 663 | 946 | 1,002 | 1,119 | 1,094 |
Other Equity | -38 | -36 | -27 | -54 | -34 |
Treasury Stock | 512 | 512 | 510 | 510 | 510 |
Total Shareholder's Equity | 285 | 568 | 631 | 719 | 714 |
Total Liabilities & Shareholder's Equity | 2,276 | 2,567 | 2,623 | 2,767 | 2,828 |
Total Common Equity | 285 | 568 | 631 | 719 | 714 |
Shares Outstanding | 36.30 | 36.30 | 36.20 | 36.20 | 36.30 |
Book Value Per Share | 7.85 | 15.65 | 17.44 | 19.85 | 19.67 |